• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子(EGF)通过不依赖受体激酶的信号传导

Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

作者信息

Deb T B, Su L, Wong L, Bonvini E, Wells A, David M, Johnson G R

机构信息

Divisions of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.

出版信息

J Biol Chem. 2001 May 4;276(18):15554-60. doi: 10.1074/jbc.M100928200. Epub 2001 Feb 5.

DOI:10.1074/jbc.M100928200
PMID:11279155
Abstract

The ErbB family of receptors, which includes the epidermal growth factor receptor (EGFR), ErbB2, ErbB3, and ErbB4, mediate signaling by EGF-like polypeptides. To better understand the role of the EGFR tyrosine kinase, we analyzed signaling by a kinase-inactive EGFR (K721M) in ErbB-devoid 32D cells. K721M alone exhibited no detectable signaling capacity, whereas coexpression of K721M with ErbB2, but not ErbB3 or ErbB4, resulted in EGF-dependent mitogen-activated protein kinase (MAPK) activation. The kinase activity, but not tyrosine phosphorylation, of ErbB2 was required for EGF-induced MAPK activation. The presence of tyrosine phosphorylation sites in K721M was not a requisite for signaling, indicating that transphosphorylation of K721M by ErbB2 was not an essential mechanism of receptor activation. Conversely, the mutated kinase domain of K721M (residues 648-973) and tyrosine phosphorylation of at least one of the receptors were necessary. EGF was found to activate the pro-survival protein kinase Akt in stable cell lines expressing K721M and ErbB2 but, unlike cells expressing wild-type EGFR, was incapable of activating signal transducers and activators of transcription (STAT) or driving cell proliferation. These results demonstrate that EGFR-ErbB2 oligomers are potent activators of MAPK and Akt, and this signaling does not require EGFR kinase activity.

摘要

受体酪氨酸激酶ErbB家族,包括表皮生长因子受体(EGFR)、ErbB2、ErbB3和ErbB4,介导表皮生长因子样多肽的信号传导。为了更好地理解EGFR酪氨酸激酶的作用,我们分析了激酶失活的EGFR(K721M)在缺乏ErbB的32D细胞中的信号传导。单独的K721M没有可检测到的信号传导能力,而K721M与ErbB2(而非ErbB3或ErbB4)共表达导致了表皮生长因子(EGF)依赖性丝裂原活化蛋白激酶(MAPK)的激活。EGF诱导的MAPK激活需要ErbB2的激酶活性,但不需要其酪氨酸磷酸化。K721M中酪氨酸磷酸化位点的存在不是信号传导的必要条件,这表明ErbB2对K721M的转磷酸化不是受体激活的基本机制。相反,K721M的突变激酶结构域(第648 - 973位氨基酸残基)和至少一种受体的酪氨酸磷酸化是必需的。在表达K721M和ErbB2的稳定细胞系中,发现EGF可激活促生存蛋白激酶Akt,但与表达野生型EGFR的细胞不同,EGF无法激活信号转导子和转录激活子(STAT)或驱动细胞增殖。这些结果表明,EGFR - ErbB2寡聚体是MAPK和Akt的有效激活剂,并且这种信号传导不需要EGFR激酶活性。

相似文献

1
Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.表皮生长因子(EGF)通过不依赖受体激酶的信号传导
J Biol Chem. 2001 May 4;276(18):15554-60. doi: 10.1074/jbc.M100928200. Epub 2001 Feb 5.
2
Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.表皮生长因子受体、c-erbB2和c-erbB3受体相互作用以及SK-BR-3和BT474乳腺癌细胞的相关细胞周期动力学
Cytometry. 2001 Aug 1;44(4):338-48. doi: 10.1002/1097-0320(20010801)44:4<338::aid-cyto1125>3.0.co;2-v.
3
An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.由激酶缺陷型表皮生长因子受体诱导的细胞酪氨酸磷酸化的不完全程序。
J Biol Chem. 1995 May 19;270(20):12085-93. doi: 10.1074/jbc.270.20.12085.
4
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.表皮生长因子和β细胞素通过共同表达的ErbB2和ErbB3受体介导信号转导。
EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608.
5
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.生长激素诱导3T3-F442A细胞中表皮生长因子(EGF)受体的磷酸化。对EGF诱导的转运和信号传导的调节。
J Biol Chem. 2003 May 23;278(21):18902-13. doi: 10.1074/jbc.M300939200. Epub 2003 Mar 14.
6
Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.用抗ErbB2单克隆抗体2C4阻断表皮生长因子或神经调节蛋白依赖性的ErbB2激活,会产生不同的下游信号传导和生长效应。
Cancer Res. 2004 Apr 1;64(7):2601-9. doi: 10.1158/0008-5472.can-03-3106.
7
ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.表皮生长因子受体(ErbB)诱导的信号转导和转录激活因子(Stat)转录因子激活是由Src酪氨酸激酶介导的。
J Biol Chem. 1999 Jun 11;274(24):17209-18. doi: 10.1074/jbc.274.24.17209.
8
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.表皮生长因子受体(EGFR)和人表皮生长因子受体2(ErbB2)的磷酸化是前列腺癌细胞对表皮生长因子(EGF)反应性增殖的可靠预测指标。
Neoplasia. 2004 Nov-Dec;6(6):846-53. doi: 10.1593/neo.04379.
9
A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.双调蛋白和表皮生长因子(EGF)促有丝分裂信号传导中对EGF受体COOH末端区域的不同需求。
J Biol Chem. 1999 Mar 26;274(13):8900-9. doi: 10.1074/jbc.274.13.8900.
10
ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.ErbB2的表达增加了通过ErbB4介导的配体信号转导的范围和效力。
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6809-14. doi: 10.1073/pnas.95.12.6809.

引用本文的文献

1
Evaluating the Effectiveness of Tyrosine Kinase Inhibitors on EGFR Mutations In Vitro.评估酪氨酸激酶抑制剂对体外表皮生长因子受体(EGFR)突变的有效性。
Int J Mol Sci. 2025 Jun 26;26(13):6157. doi: 10.3390/ijms26136157.
2
EGF, TGF- and Amphiregulin Differently Regulate Endometrium-Derived Mesenchymal Stromal/Stem Cells.表皮生长因子(EGF)、转化生长因子-β(TGF-β)和 Amphiregulin 对子宫内膜来源的间充质基质/干细胞具有不同的调节作用。
Int J Mol Sci. 2023 Aug 29;24(17):13408. doi: 10.3390/ijms241713408.
3
Ethylene-triggered subcellular trafficking of CTR1 enhances the response to ethylene gas.
乙烯触发 CTR1 的亚细胞运输增强了对乙烯气体的响应。
Nat Commun. 2023 Jan 23;14(1):365. doi: 10.1038/s41467-023-35975-6.
4
A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells and .一种新型小分子抗体HER2纳米抗体可抑制HER2阳性乳腺癌细胞的肿瘤增殖。
Front Oncol. 2021 May 12;11:669393. doi: 10.3389/fonc.2021.669393. eCollection 2021.
5
Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals.表皮生长因子受体(EGFR)在Y954位点的自磷酸化促进了同源二聚化并增强了下游信号。
Biophys J. 2020 Nov 17;119(10):2127-2137. doi: 10.1016/j.bpj.2020.10.008. Epub 2020 Oct 21.
6
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.人表皮生长因子受体2(HER2)体细胞突变与HER2阴性乳腺癌的不良生存相关。
Cancer Sci. 2017 Apr;108(4):671-677. doi: 10.1111/cas.13182. Epub 2017 Apr 21.
7
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family.表皮生长因子受体家族被低估的多态性。
Front Cell Dev Biol. 2016 Aug 22;4:88. doi: 10.3389/fcell.2016.00088. eCollection 2016.
8
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors.用于治疗头颈癌的分子靶向治疗:ErbB家族抑制剂综述
Onco Targets Ther. 2016 Apr 4;9:1927-43. doi: 10.2147/OTT.S93720. eCollection 2016.
9
SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR.SMOC与前体表皮生长因子(Pro-EGF)结合,但不通过表皮生长因子受体(EGFR)诱导细胞外信号调节激酶(Erk)磷酸化。
PLoS One. 2016 Apr 21;11(4):e0154294. doi: 10.1371/journal.pone.0154294. eCollection 2016.
10
Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy.诱导癌蛋白降解以改善靶向癌症治疗。
Neoplasia. 2015 Sep;17(9):697-703. doi: 10.1016/j.neo.2015.08.008.